About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,766 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,766 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7081-7100 of 17,766 trials

TerminatedA Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaThe primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.NCT05443724·Phoenix, Arizona and 84 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

RecruitingA Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated CardiomyopathyThe Sponsor is studying an investigational medication called danicamtiv to determine if it can help people with genetic and familial dilated cardiomyopathy (DCM).NCT07210723·Birmingham, Alabama and 77 others

CompletedA Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)Recombinant human parathyroid hormone, also known as if rhPTH(1-84), is a medicine to treat people with Hypothyroidism.NCT03324880·Chicago, Illinois and 39 others

CompletedSafety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung CancerThe purpose of this study is to evaluate the objective tumor response rate to SNS-595 in patients with small cell lung cancer (SCLC).NCT00298896·Sacramento, California and 16 others

CompletedStudy of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckA study in patients with metastatic or recurrent squamous cell cancer of the head and neck to evaluate the effectiveness of Nivolumab plus Ipilumumab vs. Nivolumab alone…NCT02823574·Tucson, Arizona and 104 others

UnknownLateral Ankle Ligament Reconstruction With InternalBrace™ AugmentationLateral ankle ligament stabilization procedures are well described in the orthopaedic literature.NCT04770818·Chicago, Illinois and 2 others

RecruitingOsimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerThis phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside…NCT04181060·Anchorage, Alaska and 602 others

CompletedStudy of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal CancerThe primary purpose of this study is to assess the safety and feasibility of giving TNFerade™ with 5-FU, Cisplatin and radiation therapy to patients with locally advanced…NCT00051480·La Jolla, California and 11 others

RecruitingA Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromeStudy BH-30236-01 is a first-in-human (FIH), Phase 1/1b, open-label, dose escalation and expansion study in participants with relapsed/refractory acute myelogenous leukemia (R/R…NCT06501196·Duarte, California and 12 others

CompletedStudy of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyThe purpose of this study is to determine if EVP-6124 (an alpha-7 nAChR agonist) enhances the cognitive abilities of subjects with Schizophrenia who are also taking stable…NCT01714661·Tucson, Arizona and 93 others

CompletedMolecular Epidemiology of Clostridium Difficile Infections in ChildrenObjectives: 1. Describe the molecular epidemiology of Clostridium Difficile infection in children in the Chicago area.NCT01957761·Chicago, Illinois

RecruitingAnticoagulation in ICH Survivors for Stroke Prevention and RecoveryPrimary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients…NCT03907046·Birmingham, Alabama and 186 others

CompletedA Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial TherapyThis is an event driven, adaptive design, a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab…NCT03149003·Birmingham, Alabama and 60 others

CompletedA Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)This is a Phase 3, randomized, double-blind, parallel-group, placebo-controlled, multicenter inpatient study to examine the efficacy and safety of KarXT in adult subjects who are…NCT04738123·Bentonville, Arkansas and 31 others

CompletedOpioid Prescription After Cesarean TrialNon-inferiority randomized trial of 5,500 women with a cesarean delivery randomized prior to discharge to either an individualized opioid prescription protocol (IOPP) that…NCT04296396·Birmingham, Alabama and 11 others

CompletedErlotinib Prevention of Oral Cancer (EPOC)The goal of this clinical research study is to learn if erlotinib hydrochloride (Tarcevaâ (OSI-774 ) can prevent cancer in the mouth of people with a high risk of developing…NCT00402779·Atlanta, Georgia and 3 others

Approved for marketingOlaratumab (LY3012207) Patient Access for Soft Tissue SarcomaThe purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of soft tissue sarcoma…NCT03994627·Glendale, Arizona and 88 others

CompletedTBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based RegimenPrimary objective: To determine the rate of confirmed treatment failure and relapse with an intermittent rifabutin-based regimen for the treatment of isoniazid and…NCT00023361·Little Rock, Arkansas and 22 others

Active not recruitingSleep for Stroke Management and Recovery TrialThe purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces…NCT03812653·Birmingham, Alabama and 115 others

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

PreviousPage 355 of 889Next

in Chicago

Heart Diseasein Chicago